Health News and Scoops

D-Psoria products are the first topical, non-prescription cosmeceuticals for the redness, scaling and flaking associated with severe skin conditions. Developed by Astrel Genome Ltd., D-Psoria is being marketed in the U.S. by MediNiche Pharmaceuticals, St. Louis, Missouri.

D-Psoria products were developed in conjunction with doctors, estheticians and ayurvedic (science of life) natural principles. All products utilize natural ingredients, unique herbal extracts and key minerals, that when applied topically are designed specifically to help regenerate new, healthy skin.

D-Psoria is ideal for use by patients and consumers that wish to try a natural product as an alternative prior to considering prescription drug therapy. It is being promoted to medical and skincare professionals for recommendation to patients and consumers as a pre-pharmacotherapy consideration.

(Source) Press

Women in high risk groups for developing breast cancer are often given medications that reduce a particular genome of breast cancer but increase their risk for other breast cancers and blood clots according researchers from Oregon Health & Science University. Their findings were published in the September 15th issue of the Annals of Internal Medicine.

Daily walking has been shown to be more effective in reducing breast cancer risks without dangerous side effects in numerous studies. According to a 20-year Nurses’ Health Study of 72,000 female nurses, walking for three hours a week, a mere 30 minutes a day is associated with a reduced risk of breast cancer.

Another study published in the New England Journal of Medicine focused on 26,000 women and found similar results with the risk of breast cancer reduced by 72%.

(Source) Press